Viridian Therapeutics Statistics
Total Valuation
VRDN has a market cap or net worth of $1.80 billion. The enterprise value is $1.09 billion.
Important Dates
The last earnings date was Tuesday, May 5, 2026, before market open.
| Earnings Date | May 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
VRDN has 103.07 million shares outstanding. The number of shares has increased by 23.41% in one year.
| Current Share Class | 103.07M |
| Shares Outstanding | 103.07M |
| Shares Change (YoY) | +23.41% |
| Shares Change (QoQ) | +8.30% |
| Owned by Insiders (%) | 0.06% |
| Owned by Institutions (%) | 102.56% |
| Float | 97.60M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 25.33 |
| Forward PS | 15.29 |
| PB Ratio | 3.54 |
| P/TBV Ratio | 3.57 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 15.34 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 15.15, with a Debt / Equity ratio of 0.08.
| Current Ratio | 15.15 |
| Quick Ratio | 14.71 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -49.07 |
Financial Efficiency
Return on equity (ROE) is -58.14% and return on invested capital (ROIC) is -36.61%.
| Return on Equity (ROE) | -58.14% |
| Return on Assets (ROA) | -33.25% |
| Return on Invested Capital (ROIC) | -36.61% |
| Return on Capital Employed (ROCE) | -52.32% |
| Weighted Average Cost of Capital (WACC) | 8.82% |
| Revenue Per Employee | $281,421 |
| Profits Per Employee | -$1.20M |
| Employee Count | 252 |
| Asset Turnover | 0.10 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +36.07% in the last 52 weeks. The beta is 0.82, so VRDN's price volatility has been lower than the market average.
| Beta (5Y) | 0.82 |
| 52-Week Price Change | +36.07% |
| 50-Day Moving Average | 19.89 |
| 200-Day Moving Average | 24.32 |
| Relative Strength Index (RSI) | 52.94 |
| Average Volume (20 Days) | 3,434,740 |
Short Selling Information
The latest short interest is 10.66 million, so 10.34% of the outstanding shares have been sold short.
| Short Interest | 10.66M |
| Short Previous Month | 10.84M |
| Short % of Shares Out | 10.34% |
| Short % of Float | 10.92% |
| Short Ratio (days to cover) | 3.37 |
Income Statement
In the last 12 months, VRDN had revenue of $70.92 million and -$303.27 million in losses. Loss per share was -$3.37.
| Revenue | 70.92M |
| Gross Profit | -268.72M |
| Operating Income | -385.70M |
| Pretax Income | -360.59M |
| Net Income | -303.27M |
| EBITDA | -385.23M |
| EBIT | -385.70M |
| Loss Per Share | -$3.37 |
Full Income StatementBalance Sheet
The company has $762.18 million in cash and $53.35 million in debt, with a net cash position of $708.83 million or $6.88 per share.
| Cash & Cash Equivalents | 762.18M |
| Total Debt | 53.35M |
| Net Cash | 708.83M |
| Net Cash Per Share | $6.88 |
| Equity (Book Value) | 636.01M |
| Book Value Per Share | 4.92 |
| Working Capital | 732.94M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$303.39 million and capital expenditures -$432,000, giving a free cash flow of -$303.82 million.
| Operating Cash Flow | -303.39M |
| Capital Expenditures | -432,000 |
| Depreciation & Amortization | 464,000 |
| Net Borrowing | 28.88M |
| Free Cash Flow | -303.82M |
| FCF Per Share | -$2.95 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -543.86% |
| Pretax Margin | -508.46% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VRDN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -23.41% |
| Shareholder Yield | -23.41% |
| Earnings Yield | -16.88% |
| FCF Yield | -16.91% |
Analyst Forecast
The average price target for VRDN is $35.77, which is 105.22% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $35.77 |
| Price Target Difference | 105.22% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (5Y) | 45.45% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 13, 2020. It was a reverse split with a ratio of 1:15.
| Last Split Date | Nov 13, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
VRDN has an Altman Z-Score of 4.88 and a Piotroski F-Score of 1.
| Altman Z-Score | 4.88 |
| Piotroski F-Score | 1 |
